Literature DB >> 26253143

A C-Peptide-Based Model of Pancreatic Insulin Secretion in Extremely Preterm Neonates in Intensive Care.

Jennifer L Dickson1, Jane Alsweiler2, Cameron A Gunn3, Christopher G Pretty3, J Geoffrey Chase3.   

Abstract

BACKGROUND: Model-based glycemic control relies on sufficiency of underlying models to describe underlying patient physiology. In particular, very preterm infant glucose-insulin metabolism can differ significantly from adults, and is relatively unstudied. In this study, C-peptide concentrations are used to develop insulin-secretion models for the purposes of glycemic control in neonatal intensive care.
METHODS: Plasma C-peptide, insulin, and blood glucose concentrations (BGC) were retrospectively analyzed from a cohort of 41 hyperglycemic very preterm (median age 27.2 [26.2-28.7] weeks) and very low birth-weight infants (median birth weight 839 [735-1000] g). A 2-compartment model of C-peptide kinetics was used to estimate insulin secretion. Insulin secretion was examined with respect to nutritional intake, exogenous and plasma insulin concentration, and BGC.
RESULTS: Insulin secretion was found to be highly variable between patients and over time, and could not be modeled with respect to age, weight, or protein or dextrose intake. In 13 of 54 samples exogenous insulin was being administered, and insulin secretion was lower. However, low data numbers make this result inconclusive. Insulin secretion was found to increase with BG, with a stronger association in female infants than males (R(2) = .51 vs R(2) = .13, and R(2) = .26 for the combined cohort).
CONCLUSIONS: A sex-based insulin secretion model was created and incorporated into a model-based glycemic control framework. Nutritional intake did not predict insulin secretion, indicating that insulin secretion is a complex function of a number of metabolic factors.
© 2015 Diabetes Technology Society.

Entities:  

Keywords:  glycemic control; insulin secretion; insulin therapy; physiological modeling; very preterm infants

Mesh:

Substances:

Year:  2015        PMID: 26253143      PMCID: PMC4738210          DOI: 10.1177/1932296815596175

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  47 in total

1.  Adverse neurodevelopmental outcome of moderate neonatal hypoglycaemia.

Authors:  A Lucas; R Morley; T J Cole
Journal:  BMJ       Date:  1988-11-19

2.  Effect of theophylline, glucagon and theophylline plus glucagon on insulin secretion in the premature infant.

Authors:  S Grasso; A Messina; N Saporito; G Reitano
Journal:  Diabetes       Date:  1970-11       Impact factor: 9.461

3.  Role of counterregulatory hormones in the catabolic response to stress.

Authors:  R A Gelfand; D E Matthews; D M Bier; R S Sherwin
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

4.  Maturation of glomerular filtration in preterm and mature babies.

Authors:  M G Coulthard
Journal:  Early Hum Dev       Date:  1985-09       Impact factor: 2.079

Review 5.  Glucose homeostasis in the micropremie.

Authors:  H M Farrag; R M Cowett
Journal:  Clin Perinatol       Date:  2000-03       Impact factor: 3.430

6.  Alterations of insulin-secreting response to glucose in human infants during the early postnatal period.

Authors:  T Nakai; M Hayashi; Y Kanazawa; K Kosaka; T Kigawa
Journal:  Endocrinol Jpn       Date:  1976-02

7.  Continuous infusion of insulin in hyperglycemic low-birth weight infants receiving parenteral nutrition with and without lipid emulsion.

Authors:  K S Kanarek; M L Santeiro; J I Malone
Journal:  JPEN J Parenter Enteral Nutr       Date:  1991 Jul-Aug       Impact factor: 4.016

8.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior.

Authors:  R P Eaton; R C Allen; D S Schade; K M Erickson; J Standefer
Journal:  J Clin Endocrinol Metab       Date:  1980-09       Impact factor: 5.958

9.  Survey of the management of neonatal hyperglycaemia in Australasia.

Authors:  Jane M Alsweiler; Carl A Kuschel; Frank H Bloomfield
Journal:  J Paediatr Child Health       Date:  2007-06-29       Impact factor: 1.954

10.  Pilot proof of concept clinical trials of Stochastic Targeted (STAR) glycemic control.

Authors:  Alicia Evans; Geoffrey M Shaw; Aaron Le Compte; Chia-Siong Tan; Logan Ward; James Steel; Christopher G Pretty; Leesa Pfeifer; Sophie Penning; Fatanah Suhaimi; Matthew Signal; Thomas Desaive; J Geoffrey Chase
Journal:  Ann Intensive Care       Date:  2011-09-19       Impact factor: 6.925

View more
  2 in total

1.  Gender diversity of insulin sensitivity markers among patients of type 2 diabetes mellitus in northern India: A cross-sectional analytical study.

Authors:  Ravi Kant; Poonam Yadav; Surekha Kishore
Journal:  J Family Med Prim Care       Date:  2020-07-30

2.  Insulin sensitivity in critically ill patients: are women more insulin resistant?

Authors:  Vincent Uyttendaele; J Geoffrey Chase; Jennifer L Knopp; Rebecca Gottlieb; Geoffrey M Shaw; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2021-01-21       Impact factor: 6.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.